A new U.S. policy creates a conditional route for two of six peptides to be taken by mouth
PharmaTher intends to develop the products in a 503A pharmacy setting through PD Labs before supporting future
DO
By Daniel Okafor · Regulatory Correspondent
Oct 29 10:01 ETSource: Stock Titan
From the source
Read at stocktitan.netA new U.S. policy creates a conditional route for two of six peptides to be taken by mouth
PharmaTher intends to develop the products in a 503A pharmacy setting through PD Labs before supporting future partners.
